Ignite Creation Date:
2025-12-25 @ 2:57 AM
Ignite Modification Date:
2026-05-14 @ 8:30 PM
Study NCT ID:
NCT05463133
Status:
RECRUITING
Last Update Posted:
2025-06-04
First Post:
2022-07-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization: